Insights

More Articles Back to Article

Treatment target identified for leukemia stem cells

Australian scientists are studying the potential for using an antibody to block interaction of the RSPO3 and LGR4 molecules and prevent self-renewal of leukemia stem cells, according to a study in the journal Cancer Cell. "Leukemia stem cells have their own protective mechanisms that make them resistant to anticancer drugs," said researcher Jenny Wang of the Children's Cancer Institute in Australia. Genetic Engineering & Biotechnology News (6/22)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!